Clinical Trial Update: Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) [NA]

View source ↗

Summary

An update on the ALCHEMIST Screening Trial, a National Cancer Institute study evaluating genetic testing in screening patients with operable stage IB-IIIA non-s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7 | NA | Status: ACTIVE_NOT_RECRUITING